Anton Simeonov

Until his retirement in April 2025, Anton Simeonov was the director of the Chemical Genomics Branch within the intramural Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), and a Principal Investigator conducting translational research within the division. Simeonov also served as the Acting Deputy Director, NCATS, and Scientific Director, Division of Preclinical Innovation, NCATS. The author or inventor on more than 300 peer-reviewed scientific publications and patents, Simeonov has a truly diverse background, ranging from bioorganic chemistry and molecular biology to clinical diagnostic research and development. He received a Ph.D. in bioorganic chemistry from University of Southern California and a B.A. in chemistry from Concordia College. Simeonov then trained as a postdoctoral fellow at the Scripps Research Institute under Richard Lerner and Kim Janda. Prior to joining NIH in November 2004, Simeonov was a senior scientist at Caliper Life Sciences, a leading developer of microfluidic technologies, where he was responsible for basic research on novel assay methodologies and development of microfluidic products for research and clinical diagnostics.